Harvard professor-turned-Vertex fellow Doug Melton (Stephanie Mitchell/Harvard)

Doug Melton to re­unite with his Sem­ma col­lab­o­ra­tors at Ver­tex to de­vel­op 'cu­ra­tive cell ther­a­pies'

A re­union is hap­pen­ing at Ver­tex Phar­ma­ceu­ti­cals as the bio­phar­ma push­es for­ward its work in type 1 di­a­betes with a lead­ing bi­ol­o­gist set to join …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.